Navigation Links
Spectrum Pharmaceuticals Announces Data From Three Oncology,Programs Presented at the American Association of Cancer Research,Annual Meeting

nced the reduction in tumor volume produced by cyclophosphamide and cisplatin. There was a 130 percent, 65 percent and 70 percent decrease in the tumor volume of animals administered with SPI (IRL)-1620 plus cyclophosphamide as compared to cyclophosphamide alone on day 10, 16 and 22, respectively. Similarly, the reduction in tumor volume in SPI (IRL)-1620 plus cisplatin treated animals was 31 percent, 68 percent and 80 percent greater on day 10, 16 and 22, respectively compared to cisplatin alone treated animals.

Conclusion

In conclusion, SPI (IRL)-1620 significantly enhanced the efficacy of cyclophosphamide and cisplatin in a preclinical model of ovarian tumor in mice.

About EOquin

EOquin (apaziquone for intravesical instillation) is a drug currently being developed for the treatment of non-invasive bladder cancer, which is a cancer that has invaded the inner most lining of the bladder. EOquin, an anti-cancer agent that becomes activated by reductase enzymes found in cancer cells, is formulated for administration directly into the urinary bladder. In a Phase 2 pilot study for which patient accrual was completed this year, EOquin instilled into the bladder following TUR-BT was well tolerated and was not absorbed in any detectable amount from the bladder wall into the bloodstream and therefore, would carry a low risk of harming the rest of the body.

Spectrum Pharmaceuticals completed a multi-center, Phase 2 clinical trial in Europe. The results of the trial showed that EOquin was well-tolerated and produced 67% CRs (complete responses) in patients, many of whom had been treated multiple times. EOquin received a Special Protocol Assessment from the U.S. Food and Drug Administration (FDA) for non-invasive bladder cancer and the Company expects to begin enrollment of the first patients in the Phase 3 trial this quarter.

About Satraplatin

Satraplatin, a fourth-generation, oral investigational drug, is a member of the plati
'"/>




Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Merck at ASCO 2007: Spectrum of Studies Reinforces Promise of Erbitux for Colorectal and Head and Neck Cancer Patients
2. AEterna Zentaris Partner, Spectrum, Discloses Detailed Phase 2 Data for Ozarelix, in BPH at Annual AUA Meeting
3. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
4. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
5. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
6. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
7. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
8. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
9. Pro-Pharmaceuticals Updates Progress of Clinical Trials & Davanat 505 (b)(2) Filings
10. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
11. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
Post Your Comments:
(Date:7/30/2015)... NEW YORK , July 30, 2015 ... releases a new research report with market ... size, share, forecast, porter analysis, recent developments, ... Global Industry Insight: Biosensors Market ...      (Logo: http://photos.prnewswire.com/prnh/20150727/756778 ) ...
(Date:7/30/2015)... AUSTIN, Texas , July 30, 2015 ... solutions company focused on gynecologic disease, announced ... 2015 financial results after the market close ... an investor conference call and webcast at ... August 13, 2015 at 4:30pm Eastern/1:30pm Pacific  ...
(Date:7/30/2015)... 30, 2015 What can be ... areas are going to grow at the fastest rates? ... revenues to 2025, assessing data, trends, opportunities and prospects ... 176 tables, charts, and graphs. Discover the most lucrative ... Our new study lets you assess forecasted sales at ...
Breaking Medicine Technology:Global Biosensors Market (Size of $12,964 Million in 2014) to Witness 10% CAGR During 2015 - 2020 2Global Biosensors Market (Size of $12,964 Million in 2014) to Witness 10% CAGR During 2015 - 2020 3Global Biosensors Market (Size of $12,964 Million in 2014) to Witness 10% CAGR During 2015 - 2020 4Global Biosensors Market (Size of $12,964 Million in 2014) to Witness 10% CAGR During 2015 - 2020 5Ophthalmic Devices Market Forecast 2015-2025 - Future Prospects for Leading Companies in Vision Care, Surgical, Diagnostic & Monitoring Devices 2Ophthalmic Devices Market Forecast 2015-2025 - Future Prospects for Leading Companies in Vision Care, Surgical, Diagnostic & Monitoring Devices 3Ophthalmic Devices Market Forecast 2015-2025 - Future Prospects for Leading Companies in Vision Care, Surgical, Diagnostic & Monitoring Devices 4Ophthalmic Devices Market Forecast 2015-2025 - Future Prospects for Leading Companies in Vision Care, Surgical, Diagnostic & Monitoring Devices 5Ophthalmic Devices Market Forecast 2015-2025 - Future Prospects for Leading Companies in Vision Care, Surgical, Diagnostic & Monitoring Devices 6
(Date:7/31/2015)... , ... July 31, 2015 , ... Physical therapy for knee osteoarthritis ... patient's quality of life. It keeps the patient from doing what they want or need ... have a hard time using the stairs. The patient's exercise regime may be limited by ...
(Date:7/31/2015)... ... July 31, 2015 , ... ... 100% organic, natural, therapeutic-grade oils from ingredients sourced all over the world, then ... “With considerable effort, we have developed the highest-quality oils in the industry, which ...
(Date:7/31/2015)... ... ... “ Crack’em ” was featured on NewsWatch as part of its monthly ... Forstrom, a technology expert and special reporter for NewsWatch, conducted the review and shared ... can be a very messy experience, especially when cracking eggs. Cracking an egg is ...
(Date:7/31/2015)... ... July 31, 2015 , ... ... wide variety of nutritional and wellness products, announced the addition of Vincent Aquilino ... massage therapy, active isolated stretching and the prevention and rehabilitation of injuries, has ...
(Date:7/31/2015)... (PRWEB) , ... July 31, 2015 , ... ... care client base, with the recent implementation of Microsoft Dynamics GP for a ... the industry, Intellitec is now supporting senior living communities in 16 states. This ...
Breaking Medicine News(10 mins):Health News:NYDNRehab Is the First Clinic in NYC to Provide APOS Therapy Based on Results of Complete Gait Analysis 2Health News:NYDNRehab Is the First Clinic in NYC to Provide APOS Therapy Based on Results of Complete Gait Analysis 3Health News:Living Pure Essential Oils takes Therepeutic Essential Oil Market by Storm 2Health News:Make Less Mess while Cooking with Crack’em 2Health News:NPI Welcomes Vincent Aquilino to Board of Directors 2Health News:Intellitec Solutions Expands Long term Care ERP Offerings to Maine 2
... MONDAY, Aug. 16 (HealthDay News) -- A new study finds that ... lower than what their wife or female partner makes, while women ... their husband or male partner. The findings suggest that disparities ... the young couples they studied. "With women, they were less ...
... We all want that summer glow that comes from a day ... implications for our health. Now Dr. Niva Shapira of Tel Aviv ... in the sun safer ― and it,s all in our food. ... Dr. Shapira has shown that a diet rich in antioxidants and ...
... 2010 Young adults who abuse amphetamines may be at ... leading from the heart, UT Southwestern Medical Center researchers have ... of American Heart Journal , researchers examined medical records ... old hospitalized from 1995 to 2007 and found that amphetamine ...
... assesses donor characteristics impacting liver transplantation outcomes, does not bear ... is suggested from large-scale, national data. Rather, hepatitis ... to poor graft survival in transplant patients, according to a ... were to confirm the effect of the Donor Risk Index ...
... implications for developing treatments against cancer and potentially deadly ... the function of proteins that can enhance the progression ... published in the journal Genes and Development . ... professor of cell biology, and Christopher Hellen, DPhil, associate ...
... researchers found that terminology and efforts to frame an ... have no effect on public opinion concerning the ongoing ... Using an experimental approach involving a nationally representative sample, ... not rhetoric, such as the use of ,same-sex couple, ...
Cached Medicine News:Health News:Infidelity Rises When She Makes More Than He Does 2Health News:Infidelity Rises When She Makes More Than He Does 3Health News:SPF on your plate 2Health News:SPF on your plate 3Health News:Amphetamine use increases risk of aortic tears in young adults, UT Southwestern researchers report 2Health News:Henry Ford Hospital study: Donor Risk Index does not impact outcomes on a small scale 2Health News:Researchers find function of proteins that can enhance the progression of viruses and cancer cells 2Health News:Rhetoric, framing efforts have little influence in same-sex marriage debate 2
Inquire...
Power Supply E865 is ideal for electrophoresis and semi-dry blotting applications. The electrical leads from Hoefer Gel apparatus are fully compatible with this new E865 power supply and there is no ...
Inquire...
... Scientific PSE Power Supply . The digital ... V and 2 A in 1 volt and ... run up to three SEA 2000® apparatus simultaneously ... preset and actual values of voltage, current and ...
Medicine Products: